Condyloma acuminatum is a clinically common sexually transmitted disease caused by human papillomavirus (HPV) infection. Because of its high incidence, strong contagiousness, easy recurrence, long treatment period, coupled with modern research shows that HPV persistent infection can lead to cervical cancer, and condyloma acuminata long-term untreated can be secondary to vulvar and anal cancer, which brings great harm to patients physically and mentally, especially the innocent infected or weak-willed, often suffering and painful. Cervical cancer is an infectious disease that can be prevented, treated, cured and eliminated. We are fully aware that cervical cancer is also caused by human papillomavirus (HPV) infection. If we can prevent HPV infection, we can say that we can prevent cervical cancer; if we don’t have HPV infection, we can say that we won’t get cervical cancer, which is already established. Only persistent HPV infection can develop into different levels of cervical precancer (CIN) or cervical cancer. Generally speaking, an HPV infection that is not cleared can develop into different grades of CIN: CIN1, CIN2, CIN3 within a year or two, and in almost 10 more years, it may develop into invasive cancer. If you are HPV positive, then you have a 28% chance of developing a CIN1 or CIN2; if you are HPV negative, almost none, only 3%; and if the HPV infection continues, then you may have a 1-2% chance of becoming cervical cancer. Many women mistakenly believe that HPV positive is a precancerous lesion of cervical cancer. In fact, there are many types of HPV, which should be treated differently. Generally speaking, the most common types of HPV infection in the genital tract are type 6, 11, 16 and 18. Among them, HPV type 6 and HPV type 11, which are often infected in the vulva, anus and vagina, are low-risk types. They are more common in women with condyloma acuminata or low-grade cervical intraepithelial lesions, but are not significantly associated with cervical carcinoma. HPV type 16 and HPV type 18, which are high-risk types. Studies of cervical cancer tissue specimens from countries around the world have found that HPV type 16 and HPV type 18 have the highest prevalence of infection in patients with cervical cancer, with HPV type 16 accounting for 50%, HPV type 18 for 14%, HPV type 45 for 8%, HPV type 31 for 5%, and the remaining types of HPV for 23%. HPV infection is not uncommon, or even relatively common, in sexually active young women under the age of 30 (18-28). If you have warts, or if your spouse or sexual partner has warts, you should be tested for cervical HPV typing, which is very important to prevent cervical cancer.